Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 26 January 2026

Sec. Breast Cancer

Volume 16 - 2026 | https://doi.org/10.3389/fonc.2026.1790586

Correction: Vitiligo associated with ribociclib therapy: a rare case report

This article is a correction to:

  1. Vitiligo associated with ribociclib therapy: a rare case report

    1. Read original article
Zirui Wang,Zirui Wang1,2Yuanrui BaiYuanrui Bai1Rihan WuRihan Wu1Yihui LiuYihui Liu3Chunhui DongChunhui Dong4Ling Chen*Ling Chen1*
  • 1Department of Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
  • 2Health Science Center, Xi’an Jiaotong University, Xi’an, China
  • 3Radiotherapy Oncology, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, China
  • 4Cardiovascular Hospital, Ninth Hospital of Xi’an, Xi’an, China

A Correction on
Vitiligo associated with ribociclib therapy: a rare case report

By Wang Z, Bai Y, Wu R, Liu Y, Dong C and Chen L (2025) Front. Oncol. 15:1669407. doi: 10.3389/fonc.2025.1669407

Affiliation “Department of Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China” was omitted from the paper. This affiliation has now been added for author ZiRui Wang.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: ribociclib, vitiligo, CDK4/6 inhibitor, breast cancer, immune-related adverse event

Citation: Wang Z, Bai Y, Wu R, Liu Y, Dong C and Chen L (2026) Correction: Vitiligo associated with ribociclib therapy: a rare case report. Front. Oncol. 16:1790586. doi: 10.3389/fonc.2026.1790586

Received: 18 January 2026; Accepted: 21 January 2026; Revised: 18 January 2026;
Published: 26 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Wang, Bai, Wu, Liu, Dong and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ling Chen, Y2xpbmdfMTIzNDVAMTYzLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.